Table 2.

Characteristics of incident lung cancer cases by Asian American, Native Hawaiian, Pacific Islander population, and non-Hispanic Whites and sex, 1990–2010a

CharacteristicsNHWChineseJapaneseFilipinoVietnameseKoreanNative HawaiianKampucheanLaotianSamoanAsian Indian, Pakistani
Total622,9749,8477,09210,4573,5132,8842,8003743764531,162
Men333,5405,8174,0186,8012,3341,6951,598234263300800
No. (%)No. (%)No. (%)No. (%)No. (%)No. (%)No. (%)No. (%)No. (%)No. (%)No. (%)
Year of diagnosis
1990–199251,732 (15.5)633 (10.9)523 (13)680 (10)155 (7.4)164 (9.7)215 (13.5)20 (8.6)33 (12.6)36 (12)47 (5.9)
1993–199549,842 (14.9)666 (11.5)531 (13.2)841 (12.4)217 (11.8)175 (10.3)200 (12.5)30 (12.8)33 (12.6)33 (11)57 (7.1)
1996–199848,811 (14.6)690 (11.9)603 (15)950 (14)272 (14.7)241 (14.2)218 (13.6)34 (14.5)26 (9.9)35 (11.7)78 (9.8)
1999–200147,841 (14.3)806 (13.9)529 (13.2)1,011 (14.9)325 (8.8)258 (15.2)243 (15.2)34 (14.5)38 (14.5)45 (15)112 (14)
2002–200445,914 (13.8)919 (15.8)613 (15.3)1,104 (16.2)356 (17.7)254 (15)226 (14.1)42 (18)43 (16.4)43 (14.3)150 (18.8)
2005–200745,430 (13.6)1,058 (18.2)643 (16)1,068 (15.7)456 (17.7)287 (16.9)237 (14.8)28 (12)38 (14.5)48 (16)164 (20.5)
2008–201043,970 (13.2)1,045 (18)576 (14.3)1,147 (16.9)553 (22.1)316 (18.6)259 (16.2)46 (19.7)52 (19.8)60 (20)192 (24)
SEER registry region
California145,799 (43.7)4,606 (79.2)1,587 (39.5)4,722 (69.4)1,953 (75)1,166 (68.8)123 (7.7)194 (82.9)197 (74.9)169 (56.3)371 (46.4)
Connecticut25,448 (7.6)49 (0.8)<5 (0.1)32 (0.5)15 (2.9)7 (0.4)<5 (0.1)6 (2.6)<5 (1.5)0 (0)40 (5)
Atlanta (metro)10,272 (3.1)37 (0.6)9 (0.2)10 (0.2)66 (0)33 (2)0 (0)<5 (1.3)8 (3)0 (0)33 (4.1)
Hawaii2,328 (0.7)537 (9.2)2,216 (55.2)1,409 (20.7)31 (8.8)173 (10.2)1,424 (89.1)0 (0)11 (4.2)101 (33.7)0 (0)
Iowa27,327 (8.2)7 (0.1)0 (0)<5 (0.1)28 (0)6 (0.4)0 (0)0 (0)14 (5.3)<5 (0.3)8 (1)
Detroit (metro)27,835 (8.4)78 (1.3)14 (0.4)41 (0.6)<5 (0)19 (1.1)0 (0)<5 (0.4)<5 (1.5)0 (0)56 (7)
New Jersey55,470 (16.6)253 (4.4)33 (0.8)295 (4.3)36 (0)161 (9.5)16 (1)0 (0)<5 (0.8)0 (0)256 (32)
New Mexico7,215 (2.2)12 (0.2)<5 (0.1)<5 (0)7 (0)<5 (0.1)<5 (0.2)0 (0)0 (0)0 (0)12 (1.5)
Utah5,732 (1.7)19 (0.3)16 (0.4)<5 (0)22 (1.5)<5 (0.2)<5 (0.2)0 (0)<5 (1.1)<5 (0.7)0 (0)
Seattle (Puget Sound)26,114 (7.8)219 (3.8)135 (3.4)284 (4.2)172 (11.8)125 (7.4)28 (1.8)30 (12.8)20 (7.6)27 (9)24 (3)
Age at diagnosis, y
<5430,548 (9.2)554 (9.5)242 (6)731 (10.8)478 (17.7)188 (11.1)254 (15.9)41 (17.5)56 (21.3)59 (19.7)169 (21.1)
55–6469,293 (20.8)988 (17)557 (13.9)1,551 (22.8)561 (35.3)374 (22.1)468 (29.3)49 (20.9)62 (23.6)106 (35.3)195 (24.4)
65–74116,546 (34.9)1,914 (32.9)1,332 (33.2)2,410 (35.4)736 (36.8)571 (33.7)544 (34)75 (32.1)67 (25.5)96 (32)245 (30.6)
75–8494,570 (28.4)1,791 (30.8)1,445 (36)1,668 (24.5)465 (10.3)452 (26.7)292 (18.3)60 (25.6)67 (25.5)36 (12)158 (19.8)
85+ years22,583 (6.8)570 (9.8)442 (11)441 (6.5)94 (0)110 (6.5)40 (2.5)9 (3.9)11 (4.2)<5 (1)33 (4.1)
Tumor histology
Adenocarcinoma102,584 (30.8)2,368 (40.7)1381 (34.4)2,559 (37.6)1,036 (0)549 (32.4)470 (29.4)96 (41)96 (36.5)100 (33.3)306 (38.3)
Squamous cell77,138 (23.1)976 (16.8)901 (22.4)1,454 (21.4)374 (0)462 (27.3)404 (25.3)44 (18.8)41 (15.6)65 (21.7)158 (19.8)
LC + OSC26,958 (8.1)428 (7.4)271 (6.7)458 (6.7)162 (0)100 (5.9)98 (6.1)17 (7.3)17 (6.5)25 (8.3)77 (9.6)
NOS83,670 (25.1)1,571 (27)1037 (25.8)1,650 (24.3)569 (0)367 (21.7)409 (25.6)59 (25.2)72 (27.4)79 (26.3)172 (21.5)
Small cell43,190 (12.9)474 (8.1)428 (10.7)680 (10)193 (0)217 (12.8)217 (13.6)18 (7.7)37 (14.1)31 (10.3)87 (10.9)
Stage at presentationa
Localized47,515 (14.3)810 (13.9)594 (14.8)885 (13)332 (13.2)214 (12.6)229 (14.3)20 (8.6)14 (5.3)27 (9)116 (14.5)
Regional69,256 (20.8)1,241 (21.3)989 (24.6)1,474 (21.7)501 (19.1)372 (22)401 (25.1)45 (19.2)42 (16)74 (24.7)179 (22.4)
Distant139,635 (41.9)2,988 (51.4)1,980 (49.3)3,553 (52.2)1,253 (54.4)830 (49)832 (52.1)136 (58.1)157 (59.7)166 (55.3)363 (45.4)
Unstaged45,447 (13.6)598 (10.3)386 (9.6)693 (10.2)206 (13.2)176 (10.4)128 (8)29 (12.4)49 (18.6)28 (9.3)66 (8.3)
Missing31,687 (9.5)180 (3.1)69 (1.7)196 (2.9)42 (0)103 (6.1)8 (0.5)<5 (1.7)<5 (0.4)5 (1.7)76 (9.5)
Women289,4344,0303,0743,6561,1791,1891,202140113153362
No. (%)No. (%)No. (%)No. (%)No. (%)No. (%)No. (%)No. (%)No. (%)No. (%)No. (%)
Year of diagnosis
1990–199237,200 (12.9)383 (9.5)271 (8.8)284 (7.8)85 (7.2)77 (6.5)116 (9.7)14 (10)10 (8.9)16 (10.5)19 (5.3)
1993–199539,174 (13.5)402 (10)356 (11.6)321 (8.8)97 (8.2)93 (7.8)150 (12.5)12 (8.6)7 (6.2)13 (8.5)26 (7.2)
1996–199841,491 (14.3)494 (12.3)422 (13.7)380 (10.4)115 (9.8)144 (12.1)154 (12.8)17 (12.1)15 (13.3)24 (15.7)35 (9.7)
1999–200142,063 (14.5)547 (13.6)422 (13.7)491 (13.4)163 (13.8)175 (14.7)179 (14.9)17 (12.1)29 (25.7)21 (13.7)47 (13)
2002–200442,864 (14.8)659 (16.4)483 (15.7)607 (16.6)215 (18.2)199 (16.7)200 (16.6)19 (13.6)18 (15.9)20 (13.1)62 (17.1)
2005–200743,823 (15.1)747 (18.5)555 (18.1)707 (19.3)231 (19.6)224 (18.8)212 (17.6)28 (20)18 (15.9)36 (23.5)84 (23.2)
2008–201042,819 (14.8)798 (19.8)565 (18.4)866 (23.7)273 (23.2)277 (23.3)191 (15.9)33 (23.6)16 (14.2)23 (15)89 (24.6)
SEER registry region
California131,786 (45.5)3,211 (79.7)1,459 (47.5)2,512 (68.7)1,005 (85.2)711 (59.8)101 (8.4)117 (83.6)92 (81.4)65 (42.5)189 (52.2)
Connecticut23,011 (8)25 (0.6)16 (0.5)23 (0.6)11 (0.9)13 (1.1)<5 (0.1)6 (4.3)<5 (2.7)0 (0)8 (2.2)
Atlanta (metro)8,611 (3)25 (0.6)14 (0.5)7 (0.2)21 (1.8)25 (2.1)0 (0)<5 (1.4)<5 (1.8)0 (0)10 (2.8)
Hawaii1,677 (0.6)377 (9.4)1,242 (40.4)696 (19)21 (1.8)177 (14.9)1,072 (89.2)0 (0)<5 (1.8)60 (39.2)0 (0)
Iowa18,775 (6.5)5 (0.1)17 (0.6)9 (0.3)5 (0.4)5 (0.4)<5 (0.2)0 (0)<5 (3.5)0 (0)<5 (0.6)
Detroit (metro)23,728 (8.2)37 (0.9)18 (0.6)39 (1.1)8 (0.7)16 (1.4)0 (0)0 (0)<5 (0.9)0 (0)15 (4.1)
New Jersey49,011 (16.9)179 (4.4)60 (2)200 (5.5)19 (1.6)95 (8)9 (0.8)0 (0)0 (0)0 (0)126 (34.8)
New Mexico5,638 (2)6 (0.2)19 (0.6)7 (0.2)<5 (0.3)5 (0.4)0 (0)0 (0)<5 (0.9)0 (0)<5 (0.3)
Utah3,748 (1.3)10 (0.3)20 (0.7)<5 (0.1)<5 (0.3)<5 (0.3)<5 (0.2)<5 (0.7)<5 (0.9)<5 (2.6)0 (0)
Seattle (Puget Sound)23,449 (8.1)155 (3.9)209 (6.8)159 (4.4)82 (7)139 (11.7)15 (1.3)14 (10)7 (6.2)24 (15.7)11 (3)
Age at diagnosis, y
<5428,034 (9.7)564 (14)177 (5.8)613 (16.8)242 (20.5)195 (16.4)174 (14.5)37 (26.4)25 (22.1)43 (28.1)78 (21.6)
55–6456,041 (19.4)632 (15.7)512 (16.7)777 (21.3)273 (23.2)260 (21.9)335 (27.9)35 (25)32 (28.3)40 (26.1)85 (23.5)
65–7495,962 (33.2)1,154 (28.6)1,090 (35.5)1,140 (31.2)309 (26.2)355 (29.9)418 (34.8)32 (22.9)24 (21.2)38 (24.8)102 (28.2)
75–8485,157 (29.4)1,173 (29.1)982 (32)875 (23.9)270 (22.9)268 (22.5)215 (17.9)28 (20)23 (20.4)27 (17.7)83 (22.9)
85+ years24,240 (8.4)507 (12.6)313 (10.2)251 (6.9)85 (7.2)111 (9.3)60 (5)8 (5.7)9 (8)5 (3.3)14 (3.9)
Tumor histology
Adenocarcinoma104,947 (36.3)2,378 (59)1,383 (45)2,249 (61.5)734 (62.3)567 (47.7)424 (35.3)86 (61.4)61 (54)71 (46.4)204 (56.4)
Squamous cell43,056 (14.9)283 (7)434 (14.1)278 (7.6)81 (6.9)150 (12.6)191 (15.9)13 (9.3)11 (9.7)13 (8.5)33 (9.1)
LC + OSC24,401 (8.4)259 (6.4)172 (5.6)216 (5.9)65 (5.5)58 (4.9)74 (6.2)8 (5.7)7 (6.2)9 (5.9)36 (9.9)
NOS74,526 (25.7)967 (24)755 (24.6)735 (20.1)249 (21.1)296 (24.9)301 (25)27 (19.3)29 (25.7)47 (30.7)79 (21.8)
Small cell42,504 (14.7)143 (3.5)330 (10.7)178 (4.9)50 (4.2)118 (9.9)212 (17.6)6 (4.3)5 (4.4)13 (8.5)10 (2.8)
Stage at presentationa
Localized50,684 (17.5)597 (14.8)539 (17.5)607 (16.6)160 (13.6)185 (15.6)191 (15.9)18 (12.9)11 (9.7)13 (8.5)58 (16)
Regional58,433 (20.2)733 (18.2)690 (22.5)685 (18.7)174 (14.8)231 (19.4)308 (25.6)24 (17.1)17 (15)23 (15)64 (17.7)
Distant115,689 (40)2,194 (54.4)1,533 (49.9)1,957 (53.5)695 (59)613 (51.6)619 (51.5)76 (54.3)66 (58.4)101 (66)173 (47.8)
Unstaged39,944 (13.8)407 (10.1)258 (8.4)312 (8.5)130 (11)120 (10.1)79 (6.6)16 (11.4)18 (15.9)14 (9.2)35 (9.7)
Missing24,684 (8.5)99 (2.5)54 (1.8)95 (2.6)20 (1.7)40 (3.4)5 (0.4)6 (4.3)<5 (0.9)<5 (1.3)32 (8.8)
  • aCounts less than five cases are suppressed for privacy consideration.